Cefotetan FDA Link

A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.

Also Known As:

Cefotan; Apacef; Apatef; Cefotetan Disodium; Cefotetan Disodium Salt; Ceftotan; ICI-156834; YM-09330; Disodium Salt, Cefotetan; Disodium, Cefotetan; ICI 156834; ICI156834; Salt, Cefotetan Disodium; YM 09330; YM09330; 5- Thia- 1- azabicyclo(4.2.0)oct- 2- ene- 2- carboxylic acid, 7- (((4- (2- amino- 1- carboxy- 2- oxoethylidene)- 1,3- dithietan- 2- yl)carbonyl)amino)- 7- methoxy- 3- (((1- methyl- 1H- tetrazol- 5- yl)thio)methyl)- 8- oxo- , (6R-(6alpha,7alpha))-

Pharmalogical Action Categories:

Anti-Bacterial Agents

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        Cephamycins: 82
        Cefotetan: 268
- Sulfur Compounds: 278
  - Thiazines: 3
    - Cephalosporins: 4007
      - Cephamycins: 82
        Cefotetan: 268
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Tetrazoles: 14
      - Cefotetan: 268
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        Cephamycins: 82
        Cefotetan: 268

Cefotetan Products